A Study of [11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult Volunteers

NCT01359852 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: [11C] JNJ-42491293
DRUG: [11C] JNJ-42491293 + JNJ-40411813
DRUG: [11C] JNJ-42491293 + JNJ-40411813
DRUG: [11C] JNJ-42491293

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.